REGINA WOODS: Open Payments
NPI 1841259272 · JAMESTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,821 in 118 payments from 20 companies in 2025. Trend: 2023 $2,504 · 2024 $2,655 · 2025 $2,821
Food & beverage: $2,821
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $495 |
| Neurocrine BioSciences, Inc. | 20 | $356 |
| E.R. Squibb & Sons, L.L.C. | 7 | $292 |
| ABBVIE INC. | 17 | $272 |
| Alkermes, Inc. | 12 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $233 |
| Axsome Therapeutics, Inc. | 5 | $167 |
| Otsuka America Pharmaceutical, Inc. | 10 | $158 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $80 |
| Janssen Scientific Affairs, LLC | 1 | $78 |
Products named: INGREZZA, AUSTEDO XR, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, Auvelity, UZEDY.
Industry payments across KY — which companies pay providers there.
